A pharmacist notices something. Three patients, all recently started on the same new medication, mention a similar mild side effect within the same week. On its own, each report seems minor, barely worth a second thought. Together, they might be an early signal worth a closer look. So the pharmacist...
Southeast Asia's pharmaceutical market continues to attract companies seeking to bring new products to patients across Malaysia, Singapore, Indonesia, and the Philippines, with the ASEAN pharmaceutical sector valued at over US$40 billion and projected to keep growing at a compound annual rate of more than 8% through the remainder of...
Southeast Asia is home to 11 countries, each with its own national drug regulatory authority, submission requirements, and approval timelines. For pharmaceutical companies planning to bring products to the region, this diversity is one of the most significant factors shaping how quickly and predictably a product can reach patients. Regulatory review...
The fertility market in Asia is undergoing a significant transformation, driven by declining birth rates, delayed parenthood, and increasing awareness of reproductive health. Across the region, infertility is now recognised as a growing healthcare concern, with global estimates indicating that approximately 1 in 6 people experience infertility...
Malaysia’s healthcare and pharmaceutical sectors continue to attract regional and international organisations seeking market entry opportunities and long-term growth. As competition intensifies, pharmaceutical, medical device, medical aesthetic, and healthcare companies are recognising that strategic marketing plays a critical role in building credibility, supporting the adoption of innovation, and strengthening market...
Pharmaceutical and healthcare companies exploring Southeast Asia increasingly identify Malaysia as a strategic entry point due to its strong regulatory framework, well-developed healthcare infrastructure, and growing demand for specialised medical solutions. As regional healthcare needs evolve and competition intensifies, Malaysia offers significant opportunities for organisations seeking sustainable market expansion and...
Malaysia’s pharmaceutical sector is poised for transformation. Market growth, digital disruption, and shifting consumer expectations are reshaping how brands engage. For companies to succeed, pharmaceutical marketing in Malaysia must evolve beyond traditional models toward strategies that are digital, data-driven, and ecosystem-based. EP Plus Group serves as an example of a...
Reaching out to healthcare professionals requires a strategic, trust-based approach. Unlike consumer campaigns, marketing and advertising to healthcare professionals must be rooted in evidence, sensitivity, and compliance. When done correctly, it enhances visibility and supports improved patient outcomes. Learn more about healthcare marketing services here: Healthcare Marketing Services in Malaysia. Why...
Healthcare marketing in Malaysia has evolved in recent years. With increasing patient expectations and digital-savvy healthcare professionals, companies must rethink how they present themselves. It is no longer just about promotions, rather, it’s about creating meaningful engagement and building trust across multiple channels. This article looks at how healthcare marketing works,...
Malaysia’s healthcare industry has seen consistent growth, supported by a combination of public and private sector efforts. Beyond hospitals and clinics, pharmaceutical and healthcare companies play a major role in shaping patient care standards. As Malaysia strengthens its position in the regional healthcare landscape, innovation and effective healthcare marketing in...
